1Yang G,Wang Y,Zeng Y,et al.Rapid health transition in China,1990-2010:findings from the Global Burden of Disease Study 2010.Lancet,2013,381:1987-2015. 被引量：1
2Vestbo J,Hurd SS,Rodriguez-Roisin R.The 2011 revision of the global strategy for the diagnosis,management and prevention of COPD (GOLD)--why and what?.Clin Respir J,2012,6:208-214. 被引量：1
3Nussbaumer-Ochsner Y,Rabe KF.Systemic manifestations of COPD.Chest,2011,139:165-173. 被引量：1
5Tschopp O,Boehler A,Speich R,et al.Osteoporosis before lung transplantation:association with low body mass index,but not with underlying disease.Am J Transplant,2002,2:167-172. 被引量：1
6Biskobing DM.COPD and osteoporosis.Chest,2002,121:609-620. 被引量：1
7van Staa TP,Leufkens HG,Cooper C.The epidemiology of corticosteroid-induced osteoporosis:a meta-analysis.Osteoporos Int,2002,13:777-787. 被引量：1
8Weatherall M,James K,Clay J,et al.Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids.Clin Exp Allergy,2008,38:1451-1458. 被引量：1
9Lee TA,Weiss KB.Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2004,169:855-859. 被引量：1
10National Clinical Guideline Centre (UK).Chronic Obstructive Pulmonary Disease:Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care[Internet].London:Royal College of Physicians (UK),2010. 被引量：1
